1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    










































































































    Determinants of Intracranial Hemorrhage Occurrence and Outcome after Neurothrombectomy Therapy: Insights from the Solitaire FR With Intention For Thrombectomy Randomized Trial | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleINTERVENTIONAL

  
      

  
      
Determinants of Intracranial Hemorrhage Occurrence and Outcome after Neurothrombectomy Therapy: Insights from the Solitaire FR With Intention For Thrombectomy Randomized Trial
  
    	
R. Raychev, R. Jahan, D. Liebeskind, W. Clark, R.G. Nogueira and J. Saver The SWIFT Trial Investigators

  
    	
American Journal of Neuroradiology December 2015,  36 (12) 2303-2307; DOI: https://doi.org/10.3174/ajnr.A4482 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
REFERENCES
  1. 1.↵
    National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87 doi:10.1056/NEJM199512143332401 pmid:7477192
    CrossRefPubMedWeb of Science
  2. 2.↵
    1. 

    2. Hallevi  H, 
    3. Barreto  AD, 
    4. Liebeskind  DS, et al
    . The HIAT score: identifying patients at high risk for poor outcome after intra arterial therapy for acute ischemic stroke. Stroke 2009;40:E164 doi:10.1161/STROKEAHA.108.000015
    FREE Full Text
  3. 3.↵
    1. 

    2. Flint  AC, 
    3. Faigeles  BS, 
    4. Cullen  SP, et al
    ; VISTA Collaboration. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA. Stroke 2013;44:3365–69 doi:10.1161/STROKEAHA.113.002794 pmid:24072004
    Abstract/FREE Full Text
  4. 4.↵
    1. 

    2. Christoforidis  GA, 
    3. Karakasis  C, 
    4. Mohammad  Y, et al
    . Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol 2009;30:165–70 doi:10.3174/ajnr.A1276 pmid:18768718
    Abstract/FREE Full Text
  5. 5.↵
    1. 

    2. Bang  OY, 
    3. Buck  BH, 
    4. Saver  JL, et al
    . Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol 2007;62:170–76 doi:10.1002/ana.21174 pmid:17683090
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. 

    2. Khatri  P, 
    3. Broderick  JP, 
    4. Khoury  JC, et al
    ; IMS I and II Investigators. Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283–87 doi:10.1161/STROKEAHA.108.522904 pmid:18772441
    Abstract/FREE Full Text
  7. 7.↵
    1. 

    2. Brekenfeld  C, 
    3. Remonda  L, 
    4. Nedeltchev  K, et al
    . Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry 2007;78:280–85 pmid:17308290
    Abstract/FREE Full Text
  8. 8.↵
    1. 

    2. Saver  JL
    . Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke 2007;38:2279–83 doi:10.1161/STROKEAHA.107.487009 pmid:17641238
    Abstract/FREE Full Text
  9. 9.↵
    1. 

    2. Larrue  V, 
    3. von Kummer  RR, 
    4. Müller  A, et al
    . Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438–41 doi:10.1161/01.STR.32.2.438 pmid:11157179
    Abstract/FREE Full Text
  10. 10.↵
    1. 

    2. Loh  Y, 
    3. Towfighi  A, 
    4. Liebeskind  DS, et al
    . Basal ganglionic infarction before mechanical thrombectomy predicts poor outcome. Stroke 2009;40:3315–20 doi:10.1161/STROKEAHA.109.551705 pmid:19661477
    Abstract/FREE Full Text
  11. 11.↵
    1. 

    2. Wahlgren  N, 
    3. Ahmed  N, 
    4. Dávalos  A, et al
    ; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275–82 doi:10.1016/S0140-6736(07)60149-4 pmid:17258667
    CrossRefPubMedWeb of Science
  12. 12.↵
    1. 

    2. Saver  JL, 
    3. Jahan  R, 
    4. Levy  EI, et al
    ; SWIFT Trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49 doi:10.1016/S0140-6736(12)61384-1 pmid:22932715
    CrossRefPubMedWeb of Science
  13. 13.↵
    1. 

    2. Gobin  YP, 
    3. Starkman  S, 
    4. Duckwiler  GR, et al
    . MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848–54 doi:10.1161/01.STR.0000147718.12954.60 pmid:15514171
    Abstract/FREE Full Text
  14. 14.↵
    1. 

    2. Smith  WS, 
    3. Sung  G, 
    4. Starkman  S, et al
    ; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38 doi:10.1161/01.STR.0000171066.25248.1d pmid:15961709
    Abstract/FREE Full Text
  15. 15.↵
    1. 

    2. Smith  WS, 
    3. Sung  G, 
    4. Saver  J, et al
    ; Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12 doi:10.1161/STROKEAHA.107.497115 pmid:18309168
    Abstract/FREE Full Text
  16. 16.↵
    Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68 doi:10.1161/STROKEAHA.108.544957 pmid:19590057
    Abstract/FREE Full Text
  17. 17.↵
    1. 

    2. Furlan  A, 
    3. Higashida  R, 
    4. Wechsler  L, et al
    ; PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. JAMA 1999;282:2003–11 doi:10.1001/jama.282.21.2003 pmid:10591382
    CrossRefPubMedWeb of Science
  18. 18.↵
    1. 

    2. Saver  JL, 
    3. Jahan  R, 
    4. Levy  EI, et al
    ; SWIFT Trialists. SOLITAIRETM with the intention for thrombectomy (SWIFT) trial: design of a randomized, controlled, multicenter study comparing the SOLITAIRETM Flow Restoration device and the MERCI Retriever in acute ischaemic stroke. Int J Stroke 2014;9:658–68 doi:10.1111/j.1747-4949.2012.00856.x pmid:23130938
    Abstract/FREE Full Text
  19. 19.↵
    1. 

    2. Shi  ZS, 
    3. Liebeskind  DS, 
    4. Loh  Y, et al
    ; UCLA Endovascular Stroke Therapy Investigators. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775–81 doi:10.1161/STROKEAHA.110.587063 pmid:21051673
    Abstract/FREE Full Text
  20. 20.↵
    1. 

    2. Akins  PT, 
    3. Amar  AP, 
    4. Pakbaz  RS, et al
    ; SWIFT Investigators. Complications of endovascular treatment for acute stroke in the SWIFT trial with Solitaire and Merci devices. AJNR Am J Neuroradiol 2014;35:524–28 doi:10.3174/ajnr.A3707 pmid:24029392
    Abstract/FREE Full Text
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Determinants of Intracranial Hemorrhage Occurrence and Outcome after Neurothrombectomy Therapy: Insights from the Solitaire FR With Intention For Thrombectomy Randomized Trial
  
    	
R. Raychev, R. Jahan, D. Liebeskind, W. Clark, R.G. Nogueira, J. Saver

  
    	
American Journal of Neuroradiology Dec 2015, 36 (12) 2303-2307; DOI: 10.3174/ajnr.A4482 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
 More in this TOC Section
INTERVENTIONAL


Show more INTERVENTIONAL

ADULT BRAIN


Show more ADULT BRAIN

 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement